Hearing deficits and low serum albumin are also risk factors for chemotherapy toxicity in the original Cancer and Aging Research Group chemotherapy toxicity score developed from the parent study population used in this analysis.4,13 Given that our current analysis is hypothesis-generating, these risk factors remain potentially relevant in predicting hospitalization risk. This evidence concerns the gene ALB and cancer.